129 filings
15-12G
INBX
Inhibrx Inc
10 Jun 24
Securities registration termination
5:10pm
S-8 POS
INBX
Inhibrx Inc
30 May 24
Registration of securities for employees (post-effective amendment)
4:34pm
S-8 POS
INBX
Inhibrx Inc
30 May 24
Registration of securities for employees (post-effective amendment)
4:34pm
S-8 POS
INBX
Inhibrx Inc
30 May 24
Registration of securities for employees (post-effective amendment)
4:33pm
S-8 POS
INBX
Inhibrx Inc
30 May 24
Registration of securities for employees (post-effective amendment)
4:33pm
POSASR
2mih1ag fz0
30 May 24
Automatic shelf registration (post-effective amendment)
4:32pm
8-K
6dy2lmzmwpxm wq8pnj
30 May 24
Termination of a Material Definitive Agreement
4:13pm
25-NSE
rggpu8hybwumr1o
30 May 24
Exchange delisting
8:39am
8-K
keidcbmx7aj7t61n
24 May 24
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
4:08pm
DEFA14A
lv5rdtw50enqpt744
20 May 24
Additional proxy soliciting materials
9:48pm
8-K
sxv69cimd iadrpophkf
17 May 24
Other Events
5:29pm
DEFA14A
ynk9kuf1
17 May 24
Additional proxy soliciting materials
4:25pm
8-K
8ng8rh6ug9nv
9 May 24
Inhibrx Reports First Quarter 2024 Financial Results
4:08pm
8-K
19z56phyun48xpug
8 May 24
Other Events
4:42pm
DEFM14A
3e0kju7 76f
26 Apr 24
Proxy related to merger
4:06pm
DEFA14A
z8cbev884kh pntu166
12 Mar 24
Additional proxy soliciting materials
4:05pm
8-K
g2jc37092nx2fuuk
12 Mar 24
Other Events
4:02pm
PREM14A
hw60 7sq9
29 Feb 24
Preliminary proxy related to merger
5:26pm
8-K
3cbobknqy11bq29j 1j
28 Feb 24
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
9:12am